Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Deborah Collyar: What's In It for Patients?

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Apr
28
Today In Oncology
RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer
Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants
ACP Issues Controversial New Breast Cancer Screening Guidelines
Educational Disparities in Young-Onset Colorectal Cancer Mortality
Breast Cancer Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxicity
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo